Codexis and Matrix Laboratories Enter Into Partnership

Codexis, a privately-held biosciences company, announced it has signed an agreement with Matrix Laboratories (Matrix), a leading provider of active pharmaceutical ingredients (APIs) to the global pharmaceutical industry, for the development and commercialization of the API for a high-value pharmaceutical product. Codexis will employ its proprietary pharmaceutical process re-engineering technology platform to develop a novel synthetic process for the product via a Codexis Thoroughbred biocatalyst.

()a href="http://biz.yahoo.com/prnews/050615/sfw017.html?.v=13" target="_blank">Yahoo News